AI-Driven Sample Identification System Integration

The contract seeks the development and integration of an AI-powered system designed to automate the identification and prioritization of influenza vaccine samples for laboratory testing, with a focus on enhancing efficiency within existing lab workflows and laboratory information management systems. The solution must seamlessly connect with current infrastructure to ensure real-time data handling, accurate sample tracking, and optimized resource allocation during high-volume testing periods, particularly during seasonal outbreaks. The system should leverage machine learning models trained on historical sample data to classify and rank samples based on risk factors, potency indicators, and testing urgency, reducing manual intervention and minimizing turnaround time. The contract is classified as a subcontract under NAICS code 541512, indicating it pertains to computational services and systems integration, and is issued by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. Responses are due by July 2, 2026, and the work is expected to be performed within the operational bounds of federal laboratory environments, though the exact location is not specified. The project emphasizes interoperability, scalability, and compliance with federal data standards to ensure long-term viability and regulatory alignment in vaccine safety monitoring.